ClinicalTrials.gg
RecruitingNCT07157124Updated Dec 29, 2025

Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students

An interventional study of Dynamic Visual Noise (DVN) and Static Visual Noise (SVN) in Craving and Alcohol Drinking, sponsored by University of Wyoming. Recruiting at 1 site in United States. Open to participants aged 18 Years to 29 Years. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by University of Wyoming · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 29 Years
Sex
All
01

Study summary

The goal of this clinical trial is to examine whether dynamic visual noise (DVN), a short video array of rapidly moving black and white squares, reduces cravings for and consumption of alcohol in college students who drink alcohol and experience cravings for alcohol at least once a week on average. A second goal of this clinical trial is to examine whether changes in attentional bias towards alcohol (that is, the tendency to pay greater mental and visual attention towards alcohol over other things in one's environment) is a mechanism by which DVN reduces alcohol cravings and consumption.

Researchers will compare DVN to static visual noise (SVN), which is a still image of black and white squares that has been used as a control condition for DVN in prior literature.

Participants will:

  1. Visit the laboratory once to complete the baseline data collection
  2. Watch the DVN or SVN every day for seven days (including the day of the laboratory visit)
  3. Complete daily follow-ups for six days following the day of the laboratory visit
  4. Complete a final follow-up on the seventh day following the laboratory visit
02

Conditions studied

  • Craving
  • Alcohol Drinking

Browse trials for

Keywords

  • alcohol craving
  • dynamic visual noise
  • alcohol consumption
  • attentional bias
  • craving
  • alcohol
  • DVN
  • static visual noise
  • SVN
03

In context

Alcohol Drinking

701 studies on the registry are indexed under Alcohol Drinking; 133 are open to participants now.

This study's planned enrollment of 62 is below the median of 122 across 607 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

University of Wyoming is the lead sponsor of 19 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Must report being between the age of 18 and 29
  2. Must report drinking alcohol at least once per week on average over the past month
  3. Must report having drank beer or alcoholic seltzers in the past month
  4. Must endorse experiencing craving at least once per week over the past month, on average
  5. Must report not currently receiving nor planning to seek any other treatment for their alcohol use within the next 30 days
  6. Must report owning a personal electronic device with access to the Internet
  7. Must report owning or having access to a computer with access to the Internet

Exclusion criteria

Exclusion Criteria:

  1. Major visual impairment (i.e., legal blindness or color blindness)
  2. History of seizures and/or diagnosed seizure disorder
  3. Current medical diagnosis provided by a qualified professional (i.e., psychologist, psychiatrist, neurologist) that is characterized by cognitive impairment (i.e., neurocognitive disorder due to traumatic brain injury, traumatic brain injury, infection, post-concussive syndrome, and intellectual disability)
  4. Concussion in the past month
  5. A current diagnosis of any substance use disorder besides alcohol use disorder, as determined by a qualified professional (i.e., psychologist, psychiatrist)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Dynamic Visual Noise (DVN)

    Other: Dynamic Visual Noise (DVN)

  • Sham comparator
    Static Visual Noise (SVN)

    Other: Static Visual Noise (SVN)

Interventions

  • OtherDynamic Visual Noise (DVN)

    DVN is a brief visual array of patterns of flickering black and white dots. In alignment with prior literature, the DVN array will consist of an 80 x 80 grid of 4 x 4 black and white pixel squares that will change at a rate of 640 frames per second. The DVN will be 30 seconds in duration, though participants will be able to keep watching for as long as desired by restarting the video of the array.

  • OtherStatic Visual Noise (SVN)

    SVN is similar to DVN, but refers to a static (or still) image of an array of black and white squares. The SVN will consist of an 80 x 80 grid of 4 x 4 black and white pixel squares. SVN has been used in previous working memory-loading studies as a control for DVN. Similar to the DVN, participants in the control group will view the SVN for at least 30 seconds (but they will be able to keep viewing it for as long as desired).

06

What researchers measure

Primary outcomes

  1. Strength of Alcohol Craving

    Strength of alcohol craving will be measured using the Craving Experiences Questionnaire - Strength (CEQ-S). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate stronger past-week cravings. Changes in mean craving will be calculated as changes in mean strength of past-week alcohol craving at follow-up relative to baseline for each condition.

    Time frame: Baseline and 1-week follow-up

  2. Frequency of Craving

    Frequency of alcohol craving will be measured using the Craving Experiences Questionnaire - Frequency (CEQ-F). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate more frequent past-week craving. Changes will be calculated as changes in mean frequency of past-week alcohol craving at follow-up relative to baseline for each condition.

    Time frame: Baseline and 1-week follow-up

  3. Alcohol Consumption

    At baseline and follow-up, participants will complete the Daily Drinking Questionnaire (DDQ) to indicate the extent of their past-week alcohol consumption. Higher total scores indicate more past-week alcohol consumption. Changes will be calculated as changes in mean past-week alcohol use at follow-up relative to baseline for each condition.

    Time frame: Baseline and 1-week follow-up

  4. Attentional Bias towards Alcohol

    Attentional bias will be measured at the initial laboratory session and at the 1-week final follow-up via the Alcohol Visual Probe task. Changes will be examined as mean changes in reaction time at follow-up minus reaction time at baseline for each condition.

    Time frame: Baseline and 1-week follow-up

Secondary outcomes

  1. Immediate Changes in Strength of Alcohol Craving Before and After DVN/SVN Task

    Participants will view their assigned intervention (i.e., DVN or SVN) as part of the initial baseline visit. Participants will first undergo a craving induction paradigm. Participants will then complete the CEQ-Strength-Now (CEQ-S-N) to indicate the strength of their current craving. Then, participants will view the DVN or SVN (depending on their assigned condition). After viewing the task, participants will complete the CEQ-S-N again. Higher average scores on the CEQ-S-N indicate stronger current moment cravings. Immediate changes in craving will be calculated as the average CEQ-S-N score before viewing the task minus average CEQ-S-N score after viewing the task. A mean change score will be calculated for each condition.

    Time frame: Baseline

  2. Immediate Changes in Strength of Craving Before and After DVN/SVN

    During the intervention phase, participants will be able to freely access their assigned intervention whenever they experience a craving. When they access the intervention, participants will first be asked to indicate, using a 0-100 Visual Analogue Scale (VAS), the strength of their current cravings for alcohol (i.e., "How strong is your craving for alcohol RIGHT NOW?"). They will then view their assigned intervention for at least 30 seconds. Immediately after viewing their intervention, they will complete the same VAS item. The change score will be calculated as the craving score before viewing minus the craving score after each viewing. A mean change score will be calculated for each condition.

    Time frame: 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up

Other outcomes

  1. Changes in Negative Affect from Baseline to Final Follow-Up

    Negative affect (NA) is proposed to be an associative stimulus that may elicit cravings under the Elaborated Intrusion theory. However, DVN has never been examined in the context of affect. As such, the one and only exploratory aim of the study is to examine whether DVN affects NA, longitudinally and/or immediately. NA will be measured through the use of the NA subscale of the Positive and Negative Affect Schedule (PANAS) at baseline and final follow-up. Changes will be calculated as changes in mean NA at follow-up relative to baseline. Mean change scores will be calculated for each condition.

    Time frame: Baseline and 1-week follow-up

  2. Changes in Negative Affect Immediately after Viewing DVN/SVN

    Negative affect (NA) is proposed to be an associative stimulus that may elicit cravings under the Elaborated Intrusion theory. However, DVN has never been examined in the context of affect. As such, the one and only exploratory aim of the study is to examine whether DVN affects NA, longitudinally and/or immediately. NA will be measured through the use of the NA subscale of the Positive and Negative Affect Schedule (PANAS). Participants will complete the measure immediately before and after viewing the DVN/SVN during their baseline session. Changes in NA will be calculated as average NA score after viewing minus average NA score before viewing. Mean change scores will be calculated for each condition.

    Time frame: Baseline

  3. Past-year Alcohol Use Severity

    To characterize and describe the sample in terms of their alcohol use and related experiences, participants will complete the Alcohol Symptom Checklist (ASC), a measure of alcohol use severity wherein each item corresponds to a diagnostic criteria of alcohol use disorder outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition. Higher total scores indicate more severe past-year alcohol use. Mean scores will be calculated for each condition.

    Time frame: Baseline

  4. Past-month Negative Alcohol Consequences

    To characterize and describe the sample in terms of their alcohol use and related experiences, participants will complete the Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ) at baseline. Higher total scores indicate more negative alcohol consequences experienced in the past month. Mean scores will be calculated for each condition.

    Time frame: Baseline

  5. Past-month Alcohol Use

    To characterize and describe the sample in terms of their alcohol use and related experiences, participants will complete the DDQ for their past-month alcohol use at baseline. Higher total scores indicate greater quantity and frequency of alcohol use. Mean past-month alcohol use will be calculated for each condition.

    Time frame: Baseline

  6. Attention Validation

    During the intervention period, participants will have free access to their assigned intervention. After they view the intervention, they will be asked two questions regarding the extent to which they paid attention to the intervention. Questions will include: 1. How many times did you look away from the task, even if only for a brief moment? 2. If you looked away at any point, approximately how long did you look away for in total? (Participants select a response option between "N/A; I did not look away" to 15+ seconds). Average number of times and average duration of looking away will be calculated for each condition.

    Time frame: 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up

  7. Number of Times Intervention was Viewed / Acceptability & Feasibility

    During the intervention period, participants will have free access to their assigned intervention and be instructed to view it at least once per day but ideally any time they experience a craving. The average number of times the intervention was accessed will be calculated for each condition as an indicator of acceptability and feasibility.

    Time frame: 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up

  8. Daily Alcohol Consumption

    We will be gathering data on whether participants have consumed alcohol that day, when the most recent time they consumed alcohol was, and whether they are currently under the influence of alcohol. After participants finish viewing their assigned task, answer questions about their current craving, and answer the attention validation items, they will answer the following questions about their recent alcohol use: 1. Have you consumed any alcohol since the last time you completed this task? 2. Approximately, how many hours has it been since your last alcoholic drink (round to the closest hour)? 3. Are you currently experiencing any effects of alcohol? That is, have you recently consumed alcohol and are experiencing alcohol intoxication (i.e., feeling "tipsy" or "drunk"?)

    Time frame: 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up

07

Study locations

1 of 1 sites recruiting
  • University of Wyoming
    Laramie, Wyoming 82072, United States
    Recruiting
    • Emma L Winterlind, MPS · Contactewinterl@uwyo.edu · 307-314-2177
    • Alison Looby, PhD · Contactalooby@uwyo.edu
    • Emma L Winterlind, MPS · Principal investigator
    • Alison Looby, Ph.D · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07157124
Lead sponsor
University of Wyoming
Responsible party
Emma Winterlind (Clinical Psychology Doctoral Student, University of Wyoming) — Principal investigator
First posted
Sep 5, 2025
Start date
Sep 22, 2025
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Dec 29, 2025

Study contacts

Emma Winterlind, MPS
Contact
ewinterl@uwyo.edu
307-314-2177
Alison Looby, PhD
Contact
alooby@uwyo.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion